The Medicines and Healthcare products Regulatory Agency (MHRA) has given marketing authorisation for Mounjaro, a new therapy, to manage type 2 diabetes in adults. This authorization comes after encouraging results from https://zubairjiip875960.pointblog.net/latest-medication-approved-in-the-uk-for-type-2-diabetes-90750790